TOP 1% RESEARCHER
Clarivate Highly Cited (Top 1% Globally)
Life Sciences • Medicinal Chemistry
Founder • NGCEF Foundation
Prof. Mohammad Amjad Kamal
Distinguished Professor of Life Sciences • Global Pioneer in Neurodegenerative Diseases, Drug Design, Oncology & AI in Healthcare
Former U2000 Fellow • University of Sydney
NIH Collaboration (NIA Drug Design & Dev.)
Web of Science: J-2918-2014
Top 1%
Highly Cited Researcher Worldwide
700+
Articles in Leading Medical Journals
65+
Abstracts & Keynote Presentations
Since 2010
Associate, Regional & Guest Editor
Executive Biography
Born in Pakistan, Prof. Mohammad Amjad Kamal has embarked on an internationally recognized career that spans over three decades across Saudi Arabia, Australia, China, and the United States. Renowned as a leading authority in life sciences, biochemistry, and pharmacology, he has authored over 700 scientific articles in high-impact medical journals and presented 65 conference abstracts. A cornerstone of his scientific legacy is his longstanding collaborative partnership with Dr. Nigel H. Greig, Chief of Drug Design & Development Section at the National Institute on Aging (NIH, USA), co-authoring breakthrough discoveries and designing innovative therapeutic compounds. In 2016, he established the Novel Global Community Educational Foundation (www.NGCEF.net) to foster international research collaboration and academic mentorship. Ranked among the top 1% of highly cited researchers globally by Clarivate, Prof. Kamal continues to lead pioneering initiatives in neurodegenerative disease interventions and AI-driven clinical healthcare.
International Research & Academic Journey
2000 – Present • Australia
Pharmacology, Medicinal Chemistry & NGCEF Foundation
University of Sydney (U2000 Postdoctoral Fellow, 2000–2003) • NGCEF Founder (2016)
Conducted groundbreaking research at the University of Sydney focusing on the inhibition of the rate-limiting enzyme amido phosphoribosyltransferase. Established the Novel Global Community Educational Foundation (www.NGCEF.net) to empower international young researchers and bridge academic institutions worldwide.
USA Collaboration
National Institutes of Health (NIH) Drug Design & Development
Collaboration with Dr. Nigel H. Greig, Chief of Drug Design & Development Section, NIA, NIH
Co-authored numerous landmark papers, conducted complex experimental assays, and synthesized novel therapeutic molecules targeting neurodegenerative disorders while upholding stringent IP management.
China • International Research
AI in Healthcare, Medicine & Translational Wellness
Fostered high-level academic alliances in China advancing artificial intelligence applications across precision medicine, dermatology/skincare, wellness diagnostics, and computational nursing.
1990 – 2000 • Saudi Arabia
Biochemistry Research & Regional Capacity Building
Pioneered fundamental research in biochemistry and medical sciences, significantly elevating scientific research standards and regional institutional collaborations.
Therapeutic & Research Domains
Neurodegenerative Diseases
Alzheimer’s, Parkinson’s disease & neuroprotection
Toxicology & Pharmacology
Enzyme kinetics, drug design & novel compounds
Diabetes & Metabolic Disorders
Biochemical pathways and cellular glucose regulation
Oncology & Cancer Therapeutics
Antineoplastic targets & apoptotic mechanism modeling
Artificial Intelligence in Healthcare
AI in clinical diagnostics, wellness & smart nursing
Editorial & Scholarly Identifiers